Fig. 10
From: Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma
genes CDCA8 drug sensitivity analysis. (A) The results of the sensitivity analysis for the drug CCT007093. (B) Nutlin.3a. (C) PD.0332991. (D) MK.2206. (E) AS601245. (F) Bicalutamide. (G) FH535. (H) Roscovitine. (I) VX. 702. (J) Erlotinib. (K) PF. 02341066. (L) CHIR. 99,021. (M) BMS. 754,807. (N) LFM. A13. (O) AZD6244. (P) JNK. 9 l. (Q) GDC0941. (R) DMOG. (S) PD. 0325901. (T) AZD8055. TCGA-LUAD dataset: n = 539 (LUAD) and n = 59 (Normal)